Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 1 Results

  1. 1
    313055
    Peer Reviewed

    HPV vaccine: implications for nurses and patients.

    Schmidt JV

    Nursing for Women's Health. 2007; 11(1):83-87.

    In June 2006, the approval and recommendation of a human papillomavirus (HPV) vaccine that can prevent most cervical cancers piqued interest, generated much media attention and raised questions. As a result, many young women, parents and others want to know more about this vaccine. This article will help nurses understand and communicate about issues surrounding the vaccine. HPVs are a family of more than 100 virus types that cause such problems as common warts, plantar warts, skin cancers, anal and genital warts, recurrent respiratory papillomatosis (a rare benign infection of type HPV 6 or 11 that passes from mothers to infants during childbirth), head and neck cancers, genital cancers (vagina, vulva, penile) and cervical cancer. Approximately 40 types of HPV infect the mucosal epithelium, whereas 60 types are cutaneous. More than half of sexually active women and men will be infected with one or more types of HPV in their lifetime, and some reports indicate that 80 percent of women will have anHPV infection by 50 years of age. Young women and men between 15 and 24 years of age account for half of the infections. HPV is the most common sexually transmitted infection (STI) in the United States. It's estimated that 20 million people are currently infected and 6.2 million will be newly infected each year. (excerpt)
    Add to my documents.